A citation-based method for searching scientific literature

Yuxin Zhuang, Jinxin Che, Meijuan Wu, Yu Guo, Yongjin Xu, Xiaowu Dong, Haiyan Yang. J Hematol Oncol 2022
Times Cited: 2







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.
Nathalie A Johnson, Kerry J Savage, Olga Ludkovski, Susana Ben-Neriah, Ryan Woods, Christian Steidl, Martin J S Dyer, Reiner Siebert, John Kuruvilla, Richard Klasa,[...]. Blood 2009
429
100

RNA-guided gene activation by CRISPR-Cas9-based transcription factors.
Pablo Perez-Pinera, D Dewran Kocak, Christopher M Vockley, Andrew F Adler, Ami M Kabadi, Lauren R Polstein, Pratiksha I Thakore, Katherine A Glass, David G Ousterout, Kam W Leong,[...]. Nat Methods 2013
792
50

In vivo simultaneous transcriptional activation of multiple genes in the brain using CRISPR-dCas9-activator transgenic mice.
Haibo Zhou, Junlai Liu, Changyang Zhou, Ni Gao, Zhiping Rao, He Li, Xinde Hu, Changlin Li, Xuan Yao, Xiaowen Shen,[...]. Nat Neurosci 2018
134
50

Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies.
Romain Guièze, Vivian M Liu, Daniel Rosebrock, Alexis A Jourdain, María Hernández-Sánchez, Aina Martinez Zurita, Jing Sun, Elisa Ten Hacken, Kaitlyn Baranowski, Philip A Thompson,[...]. Cancer Cell 2019
133
50



Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC/BCL2 double-hit B cell lymphoma.
Micol Ravà, Aleco D'Andrea, Paola Nicoli, Ilaria Gritti, Giulio Donati, Mirko Doni, Marco Giorgio, Daniela Olivero, Bruno Amati. Sci Transl Med 2018
31
50

Sensitizing protective tumor microenvironments to antibody-mediated therapy.
Christian P Pallasch, Ilya Leskov, Christian J Braun, Daniela Vorholt, Adam Drake, Yadira M Soto-Feliciano, Eric H Bent, Janine Schwamb, Bettina Iliopoulou, Nadine Kutsch,[...]. Cell 2014
131
50

Novel bioinformatic classification system for genetic signatures identification in diffuse large B-cell lymphoma.
Wei Zhang, Li Yang, Yu' Qi Guan, Ke' Feng Shen, Mei' Lan Zhang, Hao' Dong Cai, Jia' Chen Wang, Ying Wang, Liang Huang, Yang Cao,[...]. BMC Cancer 2020
5
50


MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents.
Arnold Bolomsky, Meike Vogler, Murat Cem Köse, Caroline A Heckman, Grégory Ehx, Heinz Ludwig, Jo Caers. J Hematol Oncol 2020
37
50

TP53 mutations are frequent events in double-hit B-cell lymphomas with MYC and BCL2 but not MYC and BCL6 translocations.
Niklas Gebauer, Veronica Bernard, Wolfgang Gebauer, Christoph Thorns, Alfred C Feller, Hartmut Merz. Leuk Lymphoma 2015
44
50

Tissue-specific activation of gene expression by the Synergistic Activation Mediator (SAM) CRISPRa system in mice.
Charleen Hunt, Suzanne A Hartford, Derek White, Evangelos Pefanis, Timothy Hanna, Clarissa Herman, Jarrell Wiley, Heather Brown, Qi Su, Yurong Xin,[...]. Nat Commun 2021
5
50

IRF4 Activity Is Required in Established Plasma Cells to Regulate Gene Transcription and Mitochondrial Homeostasis.
Michael Sze Yuan Low, Erica J Brodie, Pasquale L Fedele, Yang Liao, George Grigoriadis, Andreas Strasser, Axel Kallies, Simon N Willis, Julie Tellier, Wei Shi,[...]. Cell Rep 2019
28
50

CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency.
Navneet Matharu, Sawitree Rattanasopha, Serena Tamura, Lenka Maliskova, Yi Wang, Adelaide Bernard, Aaron Hardin, Walter L Eckalbar, Christian Vaisse, Nadav Ahituv. Science 2019
138
50

The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models.
András Kotschy, Zoltán Szlavik, James Murray, James Davidson, Ana Leticia Maragno, Gaëtane Le Toumelin-Braizat, Maïa Chanrion, Gemma L Kelly, Jia-Nan Gong, Donia M Moujalled,[...]. Nature 2016
630
50

Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias.
Rachel Thijssen, Sarah T Diepstraten, Donia Moujalled, Edward Chew, Christoffer Flensburg, Melissa X Shi, Michael A Dengler, Veronique Litalien, Sarah MacRaild, Maoshan Chen,[...]. Blood 2021
29
50


Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies.
Ilya Leskov, Christian P Pallasch, Adam Drake, Bettina P Iliopoulou, Amanda Souza, Ching-Hung Shen, Carmen D Schweighofer, Lynne Abruzzo, Lukas P Frenzel, Clemens M Wendtner,[...]. Oncogene 2013
37
50

A protein-tagging system for signal amplification in gene expression and fluorescence imaging.
Marvin E Tanenbaum, Luke A Gilbert, Lei S Qi, Jonathan S Weissman, Ronald D Vale. Cell 2014
806
50

Targeting BCL2 with venetoclax is a promising therapeutic strategy for "double-proteinexpression" lymphoma with MYC and BCL2 rearrangements.
Akiko Uchida, Yasushi Isobe, Junko Asano, Yu Uemura, Masahiro Hoshikawa, Masayuki Takagi, Ikuo Miura. Haematologica 2019
13
50

Highly efficient Cas9-mediated transcriptional programming.
Alejandro Chavez, Jonathan Scheiman, Suhani Vora, Benjamin W Pruitt, Marcelle Tuttle, Eswar P R Iyer, Shuailiang Lin, Samira Kiani, Christopher D Guzman, Daniel J Wiegand,[...]. Nat Methods 2015
818
50

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.
J M Adams, A W Harris, C A Pinkert, L M Corcoran, W S Alexander, S Cory, R D Palmiter, R L Brinster. Nature 1985
50


Targeting Bfl-1 via acute CDK9 inhibition overcomes intrinsic BH3-mimetic resistance in lymphomas.
Scott Boiko, Theresa Proia, Maryann San Martin, Gareth P Gregory, Michelle Min Wu, Neeraj Aryal, Maureen Hattersley, Wenlin Shao, Jamal C Saeh, Stephen E Fawell,[...]. Blood 2021
9
50

Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML.
C D DiNardo, I S Tiong, A Quaglieri, S MacRaild, S Loghavi, F C Brown, R Thijssen, G Pomilio, A Ivey, J M Salmon,[...]. Blood 2020
225
50

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
50

Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation.
Luke A Gilbert, Max A Horlbeck, Britt Adamson, Jacqueline E Villalta, Yuwen Chen, Evan H Whitehead, Carla Guimaraes, Barbara Panning, Hidde L Ploegh, Michael C Bassik,[...]. Cell 2014
50

Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia.
Donia M Moujalled, Giovanna Pomilio, Corina Ghiurau, Adam Ivey, Jessica Salmon, Sewa Rijal, Sarah Macraild, Lan Zhang, Tse-Chieh Teh, Ing-Soo Tiong,[...]. Leukemia 2019
102
50

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.
Lyubomir T Vassilev, Binh T Vu, Bradford Graves, Daisy Carvajal, Frank Podlaski, Zoran Filipovic, Norman Kong, Ursula Kammlott, Christine Lukacs, Christian Klein,[...]. Science 2004
50

Systematic comparison of constitutive promoters and the doxycycline-inducible promoter.
Jane Yuxia Qin, Li Zhang, Kayla L Clift, Imge Hulur, Andy Peng Xiang, Bing-Zhong Ren, Bruce T Lahn. PLoS One 2010
309
50

An Erg-driven transcriptional program controls B cell lymphopoiesis.
Ashley P Ng, Hannah D Coughlan, Soroor Hediyeh-Zadeh, Kira Behrens, Timothy M Johanson, Michael Sze Yuan Low, Charles C Bell, Omer Gilan, Yih-Chih Chan, Andrew J Kueh,[...]. Nat Commun 2020
15
50

The BCL-2 pro-survival protein A1 is dispensable for T cell homeostasis on viral infection.
Selma Tuzlak, Robyn L Schenk, Ajithkumar Vasanthakumar, Simon P Preston, Manuel D Haschka, Dimitra Zotos, Axel Kallies, Andreas Strasser, Andreas Villunger, Marco J Herold. Cell Death Differ 2017
24
50

BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines.
Delphine Merino, Gemma L Kelly, Guillaume Lessene, Andrew H Wei, Andrew W Roberts, Andreas Strasser. Cancer Cell 2018
192
50

How I treat double-hit lymphoma.
Jonathan W Friedberg. Blood 2017
82
50

Comparison of Cas9 activators in multiple species.
Alejandro Chavez, Marcelle Tuttle, Benjamin W Pruitt, Ben Ewen-Campen, Raj Chari, Dmitry Ter-Ovanesyan, Sabina J Haque, Ryan J Cecchi, Emma J K Kowal, Joanna Buchthal,[...]. Nat Methods 2016
284
50


CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes.
Luke A Gilbert, Matthew H Larson, Leonardo Morsut, Zairan Liu, Gloria A Brar, Sandra E Torres, Noam Stern-Ginossar, Onn Brandman, Evan H Whitehead, Jennifer A Doudna,[...]. Cell 2013
50

Regulation of the germinal center response by microRNA-155.
To-Ha Thai, Dinis Pedro Calado, Stefano Casola, K Mark Ansel, Changchun Xiao, Yingzi Xue, Andrew Murphy, David Frendewey, David Valenzuela, Jeffery L Kutok,[...]. Science 2007
50

Critical cancer vulnerabilities identified by unbiased CRISPR/Cas9 screens inform on efficient cancer Immunotherapy.
Margaret A Potts, Jackson A McDonald, Kate D Sutherland, Marco J Herold. Eur J Immunol 2020
4
50

Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex.
Silvana Konermann, Mark D Brigham, Alexandro E Trevino, Julia Joung, Omar O Abudayyeh, Clea Barcena, Patrick D Hsu, Naomi Habib, Jonathan S Gootenberg, Hiroshi Nishimasu,[...]. Nature 2015
50

Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats.
Marco J Herold, Jens van den Brandt, Jost Seibler, Holger M Reichardt. Proc Natl Acad Sci U S A 2008
122
50

An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo.
Brandon J Aubrey, Gemma L Kelly, Andrew J Kueh, Margs S Brennan, Liam O'Connor, Liz Milla, Stephen Wilcox, Lin Tai, Andreas Strasser, Marco J Herold. Cell Rep 2015
235
50

edgeR: a versatile tool for the analysis of shRNA-seq and CRISPR-Cas9 genetic screens.
Zhiyin Dai, Julie M Sheridan, Linden J Gearing, Darcy L Moore, Shian Su, Sam Wormald, Stephen Wilcox, Liam O'Connor, Ross A Dickins, Marnie E Blewitt,[...]. F1000Res 2014
61
50

Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments.
James H Bullard, Elizabeth Purdom, Kasper D Hansen, Sandrine Dudoit. BMC Bioinformatics 2010
50

limma powers differential expression analyses for RNA-sequencing and microarray studies.
Matthew E Ritchie, Belinda Phipson, Di Wu, Yifang Hu, Charity W Law, Wei Shi, Gordon K Smyth. Nucleic Acids Res 2015
50

Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53.
Gemma L Kelly, Stephanie Grabow, Stefan P Glaser, Leah Fitzsimmons, Brandon J Aubrey, Toru Okamoto, Liz J Valente, Mikara Robati, Lin Tai, W Douglas Fairlie,[...]. Genes Dev 2014
129
50

Double-hit B-cell lymphomas.
Sietse M Aukema, Reiner Siebert, Ed Schuuring, Gustaaf W van Imhoff, Hanneke C Kluin-Nelemans, Evert-Jan Boerma, Philip M Kluin. Blood 2011
472
50

The hallmarks of cancer.
D Hanahan, R A Weinberg. Cell 2000
50

Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors.
Carlos Lois, Elizabeth J Hong, Shirley Pease, Eric J Brown, David Baltimore. Science 2002
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.